Skip to main content
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1999;8(3):177–179. doi: 10.1080/09629359990522

Novel co-operation between eotaxin and substance-P in inducing eosinophil-derived neurotoxin release.

A El-Shazly 1, T Ishikawa 1
PMCID: PMC1781792  PMID: 10704057

Abstract

Eosinophils, chemokines, and neuropeptides are thought to play effector roles in the pathogenesis of allergic diseases such as rhinitis. Eotaxin is a novel C-C chemokine with a potent and relatively specific eosinophil chemoattractant activity that binds selectively to CCR3 receptor, however, its activity in inducing eosinophil granules proteins release is poorly characterized. This study was performed to determine whether eotaxin primes eosinophil exocytosis and whether this co-operates with the sensory neuroimmune-axis. In the present communication, we show that 10 ng/ml eotaxin primed normal human eosinophil for exaggerated eosonophil-derived neurotoxin (EDN) release stimulated by 10(-8) M Substance-P (SP). This novel priming was blocked by; 7B11 and Herbimycin A (HA), the CCR3 antagonist and the tyrosine kinase inhibitor, respectively. SDS-Page studies showed significant tyrosine phosphorylation of several protein residues induced by 10(-8) M SP only after priming with 10 ng/ml eotaxin. These results demonstrate a novel co-operation between eotaxin and SP in inducing eosinophil cytotoxicity, which at least in part involves tyrosine kinases pathway(s).

Full Text

The Full Text of this article is available as a PDF (152.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. El-Shazly A., Masuyama K., Nakano K., Eura M., Samejima Y., Ishikawa T. Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils. Int Arch Allergy Immunol. 1998 Sep;117 (Suppl 1):55–58. doi: 10.1159/000053573. [DOI] [PubMed] [Google Scholar]
  2. Kato M., Abraham R. T., Kita H. Tyrosine phosphorylation is required for eosinophil degranulation induced by immobilized immunoglobulins. J Immunol. 1995 Jul 1;155(1):357–366. [PubMed] [Google Scholar]
  3. Minshall E. M., Cameron L., Lavigne F., Leung D. Y., Hamilos D., Garcia-Zepada E. A., Rothenberg M., Luster A. D., Hamid Q. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis. Am J Respir Cell Mol Biol. 1997 Dec;17(6):683–690. doi: 10.1165/ajrcmb.17.6.2865. [DOI] [PubMed] [Google Scholar]
  4. Motojima S., Frigas E., Loegering D. A., Gleich G. J. Toxicity of eosinophil cationic proteins for guinea pig tracheal epithelium in vitro. Am Rev Respir Dis. 1989 Mar;139(3):801–805. doi: 10.1164/ajrccm/139.3.801. [DOI] [PubMed] [Google Scholar]
  5. el-Shazly A. E., Masuyama K., Ishikawa T. Mechanisms involved in activation of human eosinophil exocytosis by substance P: an in vitro model of sensory neuroimmunomodulation. Immunol Invest. 1997 Aug-Dec;26(5-7):615–629. doi: 10.3109/08820139709088545. [DOI] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES